REG - AstraZeneca PLC Investor AB - Holding(s) in Company

Investor ABAnnouncement

04/04/2019 13:30

RNS Number : 1688V
AstraZeneca PLC
04 April 2019
 


TR-1: Standard form for notification of major holdings
 



NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i










1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:


AstraZeneca PLC




1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)




Non-UK issuer








2. Reason for the notification (please mark the appropriate box or boxes with an "X")




An acquisition or disposal of voting rights








An acquisition or disposal of financial instruments








An event changing the breakdown of voting rights








Other (please specify)iii: A change in the total voting rights notified by AstraZeneca PLC on 2 April 2019.


X




3. Details of person subject to the notification obligationiv




Name


Investor AB




City and country of registered office (if applicable)


Stockholm, Sweden




4. Full name of shareholder(s) (if different from 3.)v




Name


N/A




City and country of registered office (if applicable)


N/A




5. Date on which the threshold was crossed or reachedvi:


2 April 2019




6. Date on which issuer notified (DD/MM/YYYY):


3 April 2019




7. Total positions of person(s) subject to the notification obligation








% of voting rights attached to shares (total of 8. A)


% of voting rights through financial instruments

(total of 8.B 1 + 8.B 2)


Total of both in % (8.A + 8.B)


Total number of voting rights of issuervii




Resulting situation on the date on which threshold was crossed or reached


3.93%


N/A


3.93%


1,311,755,099




Position of previous notification (if
applicable)


4.02%


N/A


4.02%
















 



8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii




A: Voting rights attached to shares




Class/type of

shares
ISIN code (if possible)


Number of voting rightsix


% of voting rights




Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)


Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)


Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)


Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)




Ordinary shares of $0.25 each
ISIN - GB0009895292


51,587,810


N/A


3.93%


N/A
















































SUBTOTAL 8. A


51,587,810


3.93%




 
 




B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))




Type of financial instrument


Expiration

datex


Exercise/

Conversion Periodxi


Number of voting rights that may be acquired if the instrument is
exercised/converted.


% of voting rights














































































SUBTOTAL 8. B 1


N/A


N/A




 
 




B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))




Type of financial instrument


Expiration

datex


Exercise/

Conversion Period xi


Physical or cash
settlementxii


Number of voting rights


% of voting rights






























































































SUBTOTAL 8.B.2


N/A


N/A




 
 
 















 



9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an "X")




Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii


X




Full chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)








Namexv


% of voting rights if it equals or is higher than the notifiable threshold


% of voting rights through financial instruments if it equals or is higher than the notifiable threshold


Total of both if it equals or is higher than the notifiable threshold




































































































10. In case of proxy voting, please identify:




Name of the proxy holder


N/A




The number and % of voting rights held


N/A




The date until which the voting rights will be held


N/A










11. Additional informationxvi




This notification has been prepared using the total voting rights figure of 1,311,755,099 ordinary shares as set out in the public announcement made by AstraZeneca PLC on 2 April 2019.










 



Place of completion


Stockholm, Sweden




Date of completion


3 April 2019



 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLBGGDSUXGBGCS